Riskpilot← Back to searchSign inGet full accessClonion AB
ABActiveOrg 5592523301Hårdvallsgatan 20Business and other management consultancy activities · NACE 7020Est. 20200 employees
Revenue 2024
SEK 0
EBITDA margin
—
-101% vs 2023
Equity ratio
99.7%
Financial strength
Net profit 2024
SEK 41K
-96% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -13K | -101% |
| Net profit | SEK 41K | -96% |
| Total assets | SEK 3,2M | -10% |
| Equity | SEK 3,2M | -8% |
| Employees | 0 | — |
Legal name
Clonion AB
Org number
5592523301
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
16 april 2020
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall konsultera och rådge verksamheter inom områdena: IT, projektledning, förändringsledning. Bolaget skall också ge bistånd med humankapital i form av interimsresurser samt verksamhetsstöd.
Address
Hårdvallsgatan 20
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 027 | 2 778 | 2 621 | 2 500 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 612 | 1 748 | 1 521 | 1 348 | −13 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 612 | 1 748 | 1 521 | 1 348 | −13 |
| Net financials | — | −1 | −1 | 16 | 66 |
| Profit before tax | 457 | 1 747 | 1 675 | 1 364 | 52 |
| Tax | −99 | −364 | −348 | −284 | −11 |
| Net profit | 358 | 1 383 | 1 327 | 1 080 | 41 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 648 | 2 042 | 3 010 | 3 537 | 3 189 |
| Equity | 383 | 1 583 | 2 641 | 3 444 | 3 178 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 110 | 305 | 369 | 93 | 11 |
| Total debt | 110 | 305 | 369 | 93 | 11 |
EBITDA margin
-1300000.0%
This company
15.8%
Market median
-8227948% vs market
20202024
Equity ratio
99.7%
This company
38.2%
Market median
+161% vs market
20202024
Return on equity
1.3%
This company
18.4%
Market median
-93% vs market
20202024
Net profit margin
4100000.0%
This company
8.1%
Market median
+50617184% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-04-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (4) | ||
| Deputy Board Member | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Clonion AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Sven Philip Dahlberg | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Nina Marika Wodzinski | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |
| Sven Niklas Dahlberg | Board of Directors | 0 companies |